Exhibit 10.55
Certain identified information has been excluded from this exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed.
Addendum No. 2 dated July 12, 2020 to
Contract No. 840/08625142/31/92-19
dd: 2019.07.31
THE SELLER
Joint Stock Company «Isotope»,
(JSC «Isotope»)
Pogodinskaya str., 22, Moscow, 119435, Russia.
Phone: +7(495) 981-96-16.
THE BUYER
The Company Isoray Medical Inc.
350 Hills Street, Suite 106
Richland, WA 99354-5411 USA
THE BUYER and THE SELLERS have mutually agreed about the following:
1. | The total activity of shipments under the Contract on calibration date is increased on [**] and is equal to [**]. |
2. | The total amount of the Ñontract is increased on USD [**] and is equal to USD [**]. |
All other terms and conditions are in accordance with Contract No. 840/08625142/31/92-19, Appendices 1 and 2, Addendum 1. The present Addendum 2 is an integral part of the Contract and may be signed via E-mail.
THE SELLER | THE BUYER | ||
/s/ Anton Shargin | /s/ Jennifer Streeter | ||
Anton Shargin | Jennifer Streeter | ||
Director of Department of Isotope Product Sales | 14 Aug 2020 | ||
JSC Isotope | Isoray - COO |